Janux Revenue and Competitors
Estimated Revenue & Valuation
- Janux's estimated annual revenue is currently $12.1M per year.
- Janux's estimated revenue per employee is $155,000
Employee Data
- Janux has 78 Employees.
- Janux grew their employee count by 42% last year.
Janux's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder, President & CEO | Reveal Email/Phone |
2 | VP at Janux Therapeutics | Reveal Email/Phone |
3 | VP, Clinical Development | Reveal Email/Phone |
4 | General Counsel | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
6 | Chief Technical Officer at Janux Therapeutics | Reveal Email/Phone |
7 | Director Quality Assurance | Reveal Email/Phone |
8 | Senior Director Regulatory Affairs | Reveal Email/Phone |
9 | Associate Director Program and Portfolio Management | Reveal Email/Phone |
10 | Senior Director, Clinical Science | Reveal Email/Phone |
Janux Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Janux?
N/A
Total Funding
78
Number of Employees
$12.1M
Revenue (est)
42%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Janux News
2022-04-20 - Janux Therapeutics (NASDAQ:JANX) Lifted to Hold at Zacks ...
According to Zacks, Janux Therapeutics Inc. is a biopharmaceutical company. It involved in developing novel T cell engager immunotherapies.
2022-04-17 - Janux Therapeutics (NASDAQ:JANX) Upgraded to Hold by ...
According to Zacks, Janux Therapeutics Inc. is a biopharmaceutical company. It involved in developing novel T cell engager immunotherapies.
2022-04-13 - Insiders might want to re-evaluate their US$1m stock purchase as Janux
Therapeutics, Inc. (NASDAQ:JANX) drops to US$570m
The Last 12 Months Of Insider Transactions At Janux Therapeutics. The insider Klaus Dorner made the biggest insider purchase in the last 12...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.9M | 78 | -15% | $13.2M |
#2 | $21.1M | 78 | 0% | N/A |
#3 | $19.1M | 78 | 15% | $3.8M |
#4 | $25.6M | 78 | 1% | N/A |
#5 | $16.4M | 78 | 5% | N/A |